Nyumbani › Lupus Nephritis › California
Majaribio ya kliniki ya Lupus Nephritis katika jimbo la California
Masomo 15 ya Lupus Nephritis yanatafuta washiriki katika vituo vya jimbo la California.
Miji katika jimbo la California
Maandishi rasmi ya utafiti (Kiingereza)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
InaajiriHatua 2
Umri 18 hadi 100 · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT05268289VIBRANT: VIB4920 for Active Lupus Nephritis
- University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla
- UCLA Medical Center: Division of Rheumatology, Los Angeles
- of California, Irvine School of Medicine Division of Rheumatology, Orange
- na zaidi ya 1
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT05201469Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
InaajiriHatua 1
Umri 18 hadi 60 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- University of California, San Francisco, San Francisco
InaajiriHatua 2
Umri 8 hadi 20 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- na zaidi ya 2
InaajiriHatua 2
Umri 12 hadi 70 · Jinsia zote · Imesasishwa 14 Sep 2026 · NCT07570862A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
InaajiriHatua 1/2
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
InaajiriHatua 1
Umri 18 hadi 74 · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Loma Linda University health, Loma Linda
- UCSF Benioff Childrens Hospital, San Francisco
InaajiriHatua 2
Umri 5 hadi 17 · Jinsia zote · Imesasishwa 3 Sep 2026 · NCT05039619A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
InaajiriHatua 1
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
InaajiriHatua 1/2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT06121297PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Purushotham & Akther Kotha MD, Inc., La Mesa
- Valerius Medical Group & Research Center of Greater Long Beach, Inc., Los Alamitos
InaajiriHatua 4
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT07611214A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Tustin
InaajiriHatua 1/2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 4 Jun 2026 · NCT06557265A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- na zaidi ya 2
InaajiriHatua 1
Umri 12 hadi 70 · Jinsia zote · Imesasishwa 22 Mei 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 110 · Jinsia zote · Imesasishwa 15 Apr 2026 · NCT05934149Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor
- Lucile Packard Children's Hospital, Palo Alto
InaajiriHatua 1/2
Umri 1 hadi 30 · Jinsia zote · Imesasishwa 17 Jul 2023 · NCT05508009Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.